Ask almost anyone in clinical research whether technology deployment is difficult and you’ll get the same answer: yes.

But our latest State of the Technology Survey suggests something more interesting beneath that agreement.

The industry’s biggest technology challenges are deeply interconnected — and every stakeholder experiences a different side of the same operational problem.

We asked sites, sponsors, and CROs about their biggest challenges with eClinical technology deployment and adoption.

The responses were remarkably aligned.

Sites identified major challenges around:

• integration with existing systems
• budget and cost
• security and privacy concerns
• technology adoption by staff

Sponsors highlighted:

• integration complexity
• training and implementation support
• site adoption challenges
• support burdens

CROs reported similar issues:

• integration across systems
• training support
• site enablement
• competing sponsor technology preferences

Across all three stakeholder groups, one issue consistently surfaced: integration and operational coordination.

That matters because the industry often frames technology problems as isolated failures:

• sites resist adoption
• sponsors deploy too many systems
• vendors don’t integrate
• CROs create inconsistency

But the data suggests something more systemic.

Clinical trial technology operates inside a highly interdependent ecosystem where every stakeholder’s decisions affect everyone else’s workflows.

A sponsor’s platform decision affects:

• CRO operations
• CRA workflows
• site staff training
• source review processes
• integration requirements

A site’s technology maturity affects:

• monitoring models
• support burdens
• implementation timelines
• interoperability possibilities

A CRO’s operational stack affects:

• sponsor visibility
• workflow consistency
• site experience
• escalation pathways

And increasingly, all of these systems are expected to work together in near real time.

That creates a level of coordination complexity the industry may still underestimate.

Because most eClinical technologies were designed to optimize individual workflows:

• EDC
• eConsent
• startup
• eISF
• recruitment
• payments
• monitoring
• source review

But clinical trial operations themselves are cross-functional, interconnected, and highly variable.

The result is an ecosystem where:

• every new platform introduces dependencies
• every integration creates governance requirements
• every workflow change affects multiple stakeholders
• every support issue propagates operationally across organizations

And yet, despite all of this complexity, the industry continues moving toward:

• more digital oversight
• more interoperability
• more automation
• more decentralized workflows
• more real-time operational visibility

That future is probably inevitable.

But the data suggests success may depend less on deploying more technology and more on improving how the ecosystem coordinates around the technology already in place.

Because the hardest part of digital transformation may not be building systems.

It may be getting an entire industry to operate together through them.